中科信息(300678.SZ):目前沒有從事腦機接口技術與設備研發
格隆匯2月2日丨中科信息(300678.SZ)在投資者互動平台表示,公司目前沒有從事腦機接口技術與設備研發。公司基於智慧醫療業務發展需要,引進腦機接口技術及設備作為輔助工具,研發基於光遺傳調控的閉環腦機接口(BMI)系統,以滿足智慧麻醉、智慧康復兩大應用場景需求。即利用引進的腦機接口設備採集病患者疼痛反應數據,傳輸到公司自主研發的醫療產品中,以提升產品的分析精準度和治療效果,並未研發腦機接口設備。公司2022年獲成都市批准成立的“腦認知與智慧醫療創新應用實驗室”室主要開展人工智能關鍵技術、醫工交叉關鍵技術研究,搭建技術研發平台、業務研發平台、移動應用研發平台,研發麻醉智能輔助維持系統升級產品、醫療設備物聯網系列化產品、區域智慧醫康養一體化 平台升級產品、醫療康復升級產品等系列產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.